Target intelligence / Profile preview

Phosphatidylserine-specific phospholipase A1 (PLA1A)

Target
PLA1A
Molecular classification
Enzyme, Carboxylic ester hydrolase, Phospholipase
01

Overview

Phosphatidylserine-specific phospholipase A1 (PLA1A) is a secreted enzyme that hydrolyzes the sn-1 acyl bond of phosphatidylserine and 1-acyl-2-lysophosphatidylserine, thus generating fatty acids and lysophosphatidylserine[3][2]. PLA1A activity participates in the remodeling of membrane phospholipids and modulates signaling related to immune cell activation, especially in mast cells in the context of apoptosis[3]. The enzyme is a member of the pancreatic lipase gene family and is characterized by a Ser-His-Asp catalytic triad, with unique substrate specificity for phosphatidylserine and a preference for short “lid” and “beta9 loop” domains which guide ligand binding and selectivity[1][2]. Mutations or dysregulation of PLA1A may contribute to inflammatory pathways and genetic syndromes involving lipid metabolism[3]. No specific approved drugs directly targeting PLA1A are currently known.

Other names
Phospholipase A1 member APLA1ANMDPSPLA1PS-PLA1ps-PLA1phosphatidylserine-specific phospholipase A1phosphatidylserine-specific phospholipase A1alpha
02

Mechanism of action

Hydrolysis of the sn-1 acyl bond of phosphatidylserine and lysophosphatidylserine leading to production of lysophosphatidylserine and fatty acids

03

Biological functions

Hydrolysis of phosphatidylserine at sn-1 positionGeneration of lysophospholipids and fatty acidsRemodeling of membrane phospholipidsEnhancement of mast cell activation and histamine production (in response to apoptotic cells)Platelet aggregationSmooth muscle contraction
04

Disease associations

Inflammation (modulation via lysophosphatidylserine signaling)Potential association with Orofacial cleft 8Potential association with Familial woolly hair syndromeOther roles relating to immune response
05

Safety considerations

No major therapeutic safety concerns described; as a lipid-modifying enzyme, effects on immune signaling or excessive activation of mast cells could be hypothetically relevant[3].

Beyond the preview

Go deeper on Phosphatidylserine-specific phospholipase A1 (PLA1A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylserine-specific phospholipase A1 (PLA1A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call